Bell Investment Advisors’s Cidara Therapeutics CDTX Stock Holding History

Bell Investment Advisors’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2	Closed	-$442	–	1869
2025 Q4	$442	Buy	+2	New	+$323	﹤0.01%	1773

Bell Investment Advisors's CDTX Position: Q1 2026 in Review

Bell Investment Advisors sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 2 shares — an estimated $442 sold.

Bell Investment Advisors first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $442 in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Bell Investment Advisors reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Bell Investment Advisors sold 2 Cidara Therapeutics shares in Q1 2026, an estimated $442.
Bell Investment Advisors first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Bell Investment Advisors's Cidara Therapeutics position peaked at $442 in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Bell Investment Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.